A randomized, double-blind comparison of LY686017, paroxetine, and placebo in the treatment of social anxiety disorder

Trial Profile

A randomized, double-blind comparison of LY686017, paroxetine, and placebo in the treatment of social anxiety disorder

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Dec 2009

At a glance

  • Drugs Tradipitant (Primary) ; Paroxetine
  • Indications Social phobia
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 15 Dec 2009 Results were publised in European Neuropsychopharmacology.
    • 15 Dec 2009 Primary endpoint 'Liebowitz Social Anxiety Scale' has not been met.
    • 14 Feb 2007 Status changed from in progress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top